Hereditary Vitreoretinal Degenerations

Retina: Fourth Edition

Volumn 1-3, Issue , 2005, Pages 519-538

  Edwards, Albert O ^a   Robertson, Joseph E ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CASEY EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 44249097945     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-02598-0.50026-4     Document Type: Chapter

References (255)

1. Gonin J Pathogenie et anatomie pathologique des decollemends retiniens. Buu Mem Soc Ophtalmol 1920, 33:1.
2. Straatsma BR, Allen RA Lattice degeneration of the retina. Trans Am Acad Ophthalmol Otolaryngol 1962, 66:600-613.
3. Shukla M, Ahuja OP A possible relationship between lattice and snail track degenerations of the retina. Am J Ophthalmol 1981, 92:482-485.
4. Bec P, Malecaze F, Arne JL, et al. [Lattice degeneration of the peripheral retina: ultrastructural study]. Ophthalmologica 1985, 191:107-113.
5. Aaberg TM, Stevens TR Snail track degeneration of the retina. Am J Ophthalmol 1972, 73:370-376.
6. Byer NE Lattice degeneration of the retina. Surv Ophthalmol 1979, 23:213-248.
7. Foos RY, Simons KB, Wheeler NC Comparison of lesions predisposing to rhegmatogenous retinal detachment by race of subjects. Am J Ophthalmol 1983, 96:644-649.
8. Byer NE Clinical study of lattice degeneration of the retina. Trans Am Acad Ophthalmol Otolaryngol 1965, 69:1065-1081.
9. Straatsma BR, Zeegen PD, Foos RY, et al. Lattice degeneration of the retina. XXX Edward Jackson Memorial Lecture. Am J Ophthalmol 1974, 77:619-649.
10. Byer NE Long-term natural history of lattice degeneration of the retina. Ophthalmology 1989, 96:1396-1401. discussion 1401-1402.
11. Benson WE, Morse PH The prognosis of retinal detachment due to lattice degeneration. Ann Ophthalmol 1978, 10:1197-1200.
12. Lorentzen SE Frequency of lattice degeneration and retinal breaks in the fellow eye in retinal detachment. Acta Ophthalmol (Copenh) 1988, 66:157-160.
13. Folk JC, Arrindell EL, Klugman MR The fellow eye of patients with phakic lattice retinal detachment. Ophthalmology 1989, 96:72-79.
14. Karlin DB, Curtin BJ Peripheral chorioretinal lesions and axial length of the myopic eye. Am J Ophthalmol 1976, 81:625-635.
15. Celorio JM, Pruett RC Prevalence of lattice degeneration and its relation to axial length in severe myopia. Am J Ophthalmol 1991, 111:20-23.
16. Weseley P, Liebmann J, Walsh JB, et al. Lattice degeneration of the retina and the pigment dispersion syndrome. Am J Ophthalmol 1992, 114:539-543.
17. Everett WG Study of a family with lattice degeneration and retinal detachment. Am J Ophthalmol 1968, 65:229-232.
18. Lewkonia I, Davies MS, Salmon JD Lattice degeneration in a family: with retinal detachment and cataract. Br J Ophthalmol 1973, 57:566-571.
19. Falls HF The genetics of lattice degeneration. Retinal diseases: symposium on differential diagnostic problems of posterior uveitis 1966, Lea & Febiger, Philadelphia, . S.J. Kimura, M.M. Caygill (Eds.).
20. Ricci A [Classification of vitreo-retinal and chorio-retinal degeneration in relation to retinal detachment]. Bibl Ophthalmol 1969, 79:183-205.
21. Murakami F, Ohba N Genetics of lattice degeneration of the retina. Ophthalmologica 1982, 185:136-140.
22. Byer NE Changes in and prognosis of lattice degeneration of the retina. Trans Am Acad Ophthalmol Otolaryngol 1974, 78:OP114-OP125.
23. Dumas J, Schepens CL Chorioretinal lesions predisposing to retinal breaks. Am J Ophthalmol 1966, 61:620-630.
24. Vu CD, Brown J, Korkko J, et al. Posterior chorioretinal atrophy and vitreous phenotype in a family with Stickler syndrome from a mutation in the COL2A1 gene. Ophthalmology 2003, 110:70-77.
25. Hagler WS, Crosswell HH Radial perivascular chorioretinal degeneration and retinal detachment. Trans Am Acad Ophthalmol Otolaryngol 1968, 72:203-216.
26. Hagler WS Radial perivascular lattice degeneration. Ann Ophthalmol 1981, 13:1096.
27. Donoso LA, Edwards AO, Frost AT, et al. Identification of a stop codon mutation in exon 2 of the collagen 2A1 gene in a large stickler syndrome family. Am J Ophthalmol 2002, 134:720-727.
28. Donoso LA, Edwards AO, Frost AT, et al. Clinical variability of Stickler syndrome: role of exon 2 of the collagen COL2A1 gene. Surv Ophthalmol 2003, 48:191-203.
29. Parma ES, Korkko J, Hagler WS, et al. Radial perivascular retinal degeneration: a key to the clinical diagnosis of an ocular variant of Stickler syndrome with minimal or no systemic manifestations. Am J Ophthalmol 2002, 134:728-734.
30. Foos RY, Simons KB Vitreous in lattice degeneration of retina. Ophthalmology 1984, 91:452-457.
31. Robinson MR, Streeten BW The surface morphology of retinal breaks and lattice retinal degeneration. A scanning electron microscopic study. Ophthalmology 1986, 93:237-246.
32. Byer NE A clinical definition of lattice degeneration of the retina and its variations. Mod Probl Ophthalmol 1975, 15:58-67.
33. Tillery WV, Lucier AC Round atrophic holes in lattice degeneration - an important cause of phakic retinal detachment. Trans Am Acad Ophthalmol Otolaryngol 1976, 81:509-518.
34. Murakami-Nagasako F, Ohba N Phakic retinal detachment associated with atrophic hole of lattice degeneration of the retina. Graefes Arch Clin Exp Ophthalmol 1983, 220:175-178.
35. Folk JC, Burton TC Bilateral phakic retinal detachment. Ophthalmology 1982, 89:815-820.
36. Benson WE, Morse PH, Nantawan P Late complications following cryotherapy of lattice degeneration. Am J Ophthalmol 1977, 84:514-516.
37. Hirose T, Lee KY, Schepens CL Snowflake degeneration in hereditary vitreoretinal degeneration. Am J Ophthalmol 1974, 77:143-153.
38. Hirose T, Wolf E, Schepens CL Retinal functions in snowflake degeneration. Ann Ophthalmol 1980, 12:1135-1146.
39. Lee MM, Ritter R, Hirose T, et al. Snowflake vitreoretinal degeneration: follow-up of the original family. Ophthalmology 2003, 110:2418-2426.
40. Pollack A, Uchenik D, Chemke J, et al. Prophylactic laser photocoagulation in hereditary snowflake vitreoretinal degeneration. A family report. Arch Ophthalmol 1983, 101:1536-1539.
41. Gheiler M, Pollack A, Uchenik D, et al. Hereditary snowflake vitreoretinal degeneration. Birth Defects Orig Artic Ser 1982, 18:577-580.
42. Snead MP, Yates JR, Williams R, et al. Stickler syndrome type 2 and linkage to the COL11A1 gene. Ann NY Acad Sci 1996, 785:331-332.
43. Richards AJ, Yates JR, Williams R, et al. A family with Stickler syndrome type 2 has a mutation in the COL11A1 gene resulting in the substitution of glycine 97 by valine in alpha 1 (XI) collagen. Hum Mol Genet 1996, 5:1339-1343.
44. Annunen S, Korkko J, Czarny M, et al. Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. Am J Hum Genet 1999, 65:974-983.
45. Robertson DM, Link TP, Rostvold JA Snowflake degeneration of the retina. Ophthalmology 1982, 89:1513-1517.
46. Chen CJ, Everett TK, Marascalco D Snowflake degeneration: an independent entity or a variant of retinitis pigmentosa?. South Med J 1986, 79:1216-1223.
47. Rudanko SL, Flage T, Hansen E, et al. Visual impairment in Nordic children. V. X-linked juvenile retinoschisis. Acta Ophthalmol (Copenh) 1993, 71:586-589.
48. Huopaniemi L, Rantala A, Forsius H, et al. Three widespread founder mutations contribute to high incidence of X-linked juvenile retinoschisis in Finland. Eur J Hum Genet 1999, 7:368-376.
49. Sabates FN Juvenile retinoschisis. Am J Ophthalmol 1966, 62:683-688.
50. Prosperi L Congenital hereditary sex-linked retinoschisis. J Pediatr Ophthalmol Strabismus 1978, 15:26-30.
51. Constantaras AA, Dobbie JG, Choromokos EA, et al. Juvenile sex-linked recessive retinoschisis in a black family. Am J Ophthalmol 1972, 74:1166-1178.
52. Brockhurst RJ Photocoagulation in congenital retinoschisis. Arch Ophthalmol 1970, 84:158-165.
53. George ND, Yates JR, Moore AT Clinical features in affected males with X-linked retinoschisis. Arch Ophthalmol 1996, 114:274-280.
54. Gieser EP, Falls HF Hereditary retinoschisis. Am J Ophthalmol 1961, 51:1193-1200.
55. Ali A, Feroze AH, Rizvi ZH, et al. Consanguineous marriage resulting in homozygous occurrence of X-linked retinoschisis in girls. Am J Ophthalmol 2003, 136:767-769.
56. Mendoza-Londono R, Hiriyanna KT, Bingham EL, et al. A Colombian family with X-linked juvenile retinoschisis with three affected females finding of a frameshift mutation. Ophthalmic Genet 1999, 20:37-43.
57. Sato M, Oshika T, Kaji Y, et al. Three novel mutations in the X-linked juvenile retinoschisis (XLRS1) gene in 6 Japanese patients, 1 of whom had Turner's syndrome. Ophthalmic Res 2003, 35:295-300.
58. Hamaguchi H, Wada I, Takigawa J, et al. [A case of congenital retinoschisis in a 34-week gestation female infant]. Nippon Ganka Gakkai Zasshi 1989, 93:575-580.
59. Shimazaki J, Matsuhashi M Familial retinoschisis in female patients. Doc Ophthalmol 1987, 65:393-400.
60. Kabanarou SA, Holder GE, Bird AC, et al. Isolated foveal retinoschisis as a cause of visual loss in young females. Br J Ophthalmol 2003, 87:801-803.
61. Lewis RA, Lee GB, Martonyi CL, et al. Familial foveal retinoschisis. Arch Ophthalmol 1977, 95:1190-1196.
62. Lorenz B Isolated foveal retinoschisis in a 7-year-old girl. Invest Ophthalmol Vis Sci 2000, 41:S883.
63. Han DP, Sieving PA, Johnson MW, et al. Foveal retinoschisis associated with senile retinoschisis in a woman. Am J Ophthalmol 1988, 106:107-109.
64. Perez Alvarez MJ, Clement Fernandez F [No X-chromosome linked juvenile foveal retinoschisis]. Arch Soc Esp Oftalmol 2002, 77:443-448.
65. Menchini U, Brancato R, Virgili G, et al. Unilateral macular retinoschisis with stellate foveal appearance in two females with myopia. Ophthalmic Surg Lasers 2000, 31:229-232.
66. Sauer CG, Gehrig A, Warneke-Wittstock R, et al. Positional cloning of the gene associated with X-linked juvenile retinoschisis. Nat Genet 1997, 17:164-170.
67. Grayson C, Reid SN, Ellis JA, et al. Retinoschisin, the X-linked retinoschisis protein, is a secreted photoreceptor protein, and is expressed and released by Weri-Rb1 cells. Hum Mol Genet 2000, 9:1873-1879.
68. Reid SN, Yamashita C, Farber DB Retinoschisin, a photoreceptor-secreted protein, and its interaction with bipolar and Muller cells. J Neurosci 2003, 23:6030-6040.
69. Wu WW, Molday RS Defective discoidin domain structure, subunit assembly, and endoplasmic reticulum processing of retinoschisin are primary mechanisms responsible for X-linked retinoschisis. J Biol Chem 2003, 278:28139-28146.
70. The Retinoschisis Consortium Functional implications of the spectrum of mutations found in 234 cases with X-linked juvenile retinoschisis. Hum Mol Genet 1998, 7:1185-1192.
71. Simonelli F, Cennamo G, Ziviello C, et al. Clinical features of X linked juvenile retinoschisis associated with new mutations in the XLRS1 gene in Italian families. Br J Ophthalmol 2003, 87:1130-1134.
72. Shinoda K, Ishida S, Oguchi Y, et al. Clinical characteristics of 14 Japanese patients with X-linked juvenile retinoschisis associated with XLRS1 mutation. Ophthalmic Genet 2000, 21:171-180.
73. Eksandh LC, Ponjavic V, Ayyagari R, et al. Phenotypic expression of juvenile X-linked retinoschisis in Swedish families with different mutations in the XLRS1 gene. Arch Ophthalmol 2000, 118:1098-1104.
74. Inoue Y, Yamamoto S, Okada M, et al. X-linked retinoschisis with point mutations in the XLRS1 gene. Arch Ophthalmol 2000, 118:93-96.
75. Manschot WA Pathology of hereditary juvenile retinoschisis. Arch Ophthalmol 1972, 88:131-138.
76. Yanoff M, Kertesz Rahn E, Zimmerman LE Histopathology of juvenile retinoschisis. Arch Ophthalmol 1968, 79:49-53.
77. Condon GP, Brownstein S, Wang NS, et al. Congenital hereditary (juvenile X-linked) retinoschisis. Histopathologic and ultrastructural findings in three eyes. Arch Ophthalmol 1986, 104:576-583.
78. Ewing CC, Ives EJ Juvenile hereditary retinoschisis. Trans Ophthalmol Soc UK 1970, 89:29-39.
79. Krause U, Vainio-Mattila B, Eriksson A, et al. Fluorescein angiographic studies on X-chromosomal retinoschisis. Acta Ophthalmol (Copenh) 1970, 48:794-807.
80. Odland M Congenital retinoschisis. Acta Ophthalmol (Copenh) 1981, 59:649-658.
81. Green JL, Jampol LM Vascular opacification and leakage in X-linked (juvenile) retinoschisis. Br J Ophthalmol 1979, 63:368-373.
82. Ando A, Takahashi K, Sho K, et al. Histopathological findings of X-linked retinoschisis with neovascular glaucoma. Graefes Arch Clin Exp Ophthalmol 2000, 238:1-7.
83. Sarin LK, Green WR, Dailey EG Juvenile retinoschisis, congenital vascular veils and hereditary retinoschisis. Am J Ophthalmol 1964, 57:793-796.
84. Keunen JE, Hoppenbrouwers RW A case of sex-linked juvenile retinoschisis with peripheral vascular anomalies. Ophthalmologica 1985, 191:146-149.
85. Bengtsson B, Linder B Sex-linked hereditary juvenile retinoschisis: presentation of two affected families. Acta Ophthalmol (Copenh) 1967, 45:411-423.
86. Peachey NS, Fishman GA, Derlacki DJ, et al. Psychophysical and electroretinographic findings in X-linked juvenile retinoschisis. Arch Ophthalmol 1987, 105:513-516.
87. Koh AH, Hogg CR, Holder GE The incidence of negative ERG in clinical practice. Doc Ophthalmol 2001, 102:19-30.
88. Sobrin L, Berrocal AM, Murray TG Retinal detachment 7 years after prophylactic schisis cavity excision in juvenile X-linked retinoschisis. Ophthalmic Surg Lasers Imaging 2003, 34:401-402.
89. Rosenfeld PJ, Flynn HW, McDonald HR, et al. Outcomes of vitreoretinal surgery in patients with X-linked retinoschisis. Ophthalmic Surg Lasers 1998, 29:190-197.
90. Ambler JS, Meyers SM, Zegarra H, et al. The management of retinal detachment complicating degenerative retinoschisis. Am J Ophthalmol 1989, 107:171-176.
91. Regillo CD, Tasman WS, Brown GC Surgical management of complications associated with X-linked retinoschisis. Arch Ophthalmol 1993, 111:1080-1086.
92. Ferrone PJ, Trese MT, Lewis H Vitreoretinal surgery for complications of congenital retinoschisis. Am J Ophthalmol 1997, 123:742-747.
93. Schulman J, Peyman GA, Jednock N, et al. Indications for vitrectomy in congenital retinoschisis. Br J Ophthalmol 1985, 69:482-486.
94. Sneed SR, Blodi CF, Folk JC, et al. Pars plana vitrectomy in the management of retinal detachments associated with degenerative retinoschisis. Ophthalmology 1990, 97:470-474.
95. Trese MT, Ferrone PJ The role of inner wall retinectomy in the management of juvenile retinoschisis. Graefes Arch Clin Exp Ophthalmol 1995, 233:706-708.
96. Lomeo MD, Diaz-Rohena R, Lambert HM Use of perfluorocarbon liquid in the repair of retinoschisis retinal detachments. J Ophthalmic Nurs Technol 1997, 16:18-21.
97. Aslan O, Batman C, Cekic O, et al. The use of perfluorodecalin in retinal detachments with retinoschisis. Ophthalmic Surg Lasers 1998, 29:818-821.
98. Arden GB, Gorin MB, Polkinghorne PJ, et al. Detection of the carrier state of X-linked retinoschisis. Am J Ophthalmol 1988, 105:590-595.
99. Sieving PA, Yashar BM, Ayyagari R Juvenile retinoschisis: a model for molecular diagnostic testing of X-linked ophthalmic disease. Trans Am Ophthalmol Soc 1999, 97:451-464. discussion 464-469.
100. Alexander RL, Shea M Wagner's disease. Arch Ophthalmol 1965, 74:310-318.
101. Weleber RG The effect of age on human cone and rod Ganzfeld electroretinograms. Invest Ophthalmol Vis Sci 1981, 20:392-399.
102. Weleber RG, Eisner A Retinal function and physiological studies. Retinal Dystrophies and degenerations 1988, Raven, New York. D.A. Newsome (Ed.).
103. Godel V, Nemet P, Lazar M The Wagner-Stickler syndrome complex. Doc Ophthalmol 1981, 52:179-188.
104. Marmor MF, Arden GB, Nilsson SEG, et al. Standard for clinical electroretinography. Arch Ophthalmol 1989, 107:816-819.
105. Liberfarb RM, Hirose T, Holmes LB The Wagner-Stickler syndrome: a study of 22 families. J Pediatr 1981, 99:394-399.
106. Wagner H Ein bisher unbekanntes erbleiden des auges (degeneratio hyaloideo-retinalis hereditaria), beobachtet im Kanton Zurich. Klinische monatsblatter fur augenheilkunde 1938, 100:840-857.
107. Zech JC, Morle L, Vincent P, et al. Wagner vitreoretinal degeneration with genetic linkage refinement on chromosome 5q13-q14. Graefes Arch Clin Exp Ophthalmol 1999, 237:387-393.
108. Perveen R, Hart-Holden N, Dixon MJ, et al. Refined genetic and physical localization of the Wagner disease (WGN1) locus and the genes CRTL1 and CSPG2 to a 2- to 2.5-cM region of chromosome 5q14.3. Genomics 1999, 57:219-226.
109. Graemiger RA, Niemeyer G, Schneeberger SA, et al. Wagner vitreoretinal degeneration. Follow-up of the original pedigree. Ophthalmology 1995, 102:1830-1839.
110. Jansen LM Degeratio hyaloideo-retinalis hereditaria. Ophthalmologica 1962, 144:348-353.
111. Brown DM, Kimura AE, Weingeist TA, et al. Erosive vitreoretinopathy. A new clinical entity. Ophthalmology 1994, 101:694-704.
112. Black GC, Perveen R, Wiszniewski W, et al. A novel hereditary developmental vitreoretinopathy with multiple ocular abnormalities localizing to a 5-cM region of chromosome 5q13-q14. Ophthalmology 1999, 106:2074-2081.
113. Bohringer HR, Dieterle P, Landolt E Zur Klinik und pathologie der degeneratio hyaloideo-retinalis hereditaria (Wagner). Ophthalmologica 1960, 139:330-338.
114. Pinckers A [Wagner's syndrome: electro-oculography and color sense]. Ann Ocul (Paris) 1970, 203:569-578.
115. Pinckers A, Jansen LM Wagner's syndrome: (degeneration hyaloideo-retinalis hereditaria). Documenta Ophthalmol 1974, 37:245.
116. Maumenee IH Vitreoretinal degeneration as a sign of generalized connective tissue diseases. Am J Ophthalmol 1979, 88:432-449.
117. Brown DM, Graemiger RA, Hergersberg M, et al. Genetic linkage of Wagner disease and erosive vitreoretinopathy to chromosome 5q13-14 [see comments]. Arch Ophthalmol 1995, 113:671-675.
118. Fryer AE, Upadhyaya M, Littler M, et al. Exclusion of COL2A1 as a candidate gene in a family with Wagner-Stickler syndrome. J Med Genet 1990, 27:91-93.
119. Lisch W, Ullerich K [Degeneratio hyaloideo-retinalis hereditaria Wagner (author's transl)]. Klin Monatsbl Augenheilkd 1978, 173:774-785.
120. Waxman SL, Bergen RL Wagner's vitreoretinal degeneration. Ann Ophthalmol 1980, 12:1150-1151.
121. Snead M, Richards A A frame shift mutation in a tissue-specific alternatively spliced exon of collagen 2a1 in Wagner's vitreoretinal degeneration. Am J Ophthalmol 2002, 134:473. author reply 473-474.
122. Gupta SK, Leonard BC, Damji KF, et al. A frame shift mutation in a tissue-specific alternatively spliced exon of collagen 2A1 in Wagner's vitreoretinal degeneration. Am J Ophthalmol 2002, 133:203-210.
123. Wille H A family with vitreo-tapeto-retino-choroidal degeneration with dominant transmission. Acta Ophthalmol 1980, 58:148-157.
124. Stickler GB, Belau PG, Farrell FJ, et al. Hereditary progressive arthro-ophthalmopathy. Mayo Clin Proc 1965, 40:433-455.
125. Stickler GB, Pugh DG Hereditary progressive arthro-ophthalmopathy. II. Additional observations on vertebral abnormalities, a hearing defect, and a report of a similar case. Mayo Clin Proc 1967, 40:433-455.
126. Knowlton RG, Weaver EJ, Struyk AF, et al. Genetic linkage analysis of hereditary arthro-ophthalmopathy (Stickler syndrome) and the type II procollagen gene. Am J Hum Genet 1989, 45:681-688.
127. Vintiner GM, Temple IK, Middleton-Price HR, et al. Genetic and clinical heterogeneity of Stickler syndrome. Am J Med Genet 1991, 41:44-48.
128. Bonaventure J, Philippe C, Plessis G, et al. Linkage study in a large pedigree with Stickler syndrome: exclusion of COL2A1 as the mutant gene. Hum Genet 1992, 90:164-168.
129. Ahmad NN, Ala-Kokko L, Knowlton RG, et al. Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthro-ophthalmopathy). Proc Natl Acad Sci USA 1991, 88:6624-6627.
130. Ahmad NN, McDonald-McGinn DM, Zackai EH, et al. A second mutation in the type II procollagen gene (COL2AI) causing Stickler syndrome (arthro-ophthalmopathy) is also a premature termination codon. Am J Hum Genet 1993, 52:39-45.
131. Freddi S, Savarirayan R, Bateman JF Molecular diagnosis of Stickler syndrome: a COL2A1 stop codon mutation screening strategy that is not compromised by mutant mRNA instability. Am J Med Genet 2000, 90:398-406.
132. Van Der Hout AH, Verlind E, Beemer FA, et al. Occurrence of deletion of a COL2A1 allele as the mutation in Stickler syndrome shows that a collagen type II dosage effect underlies this syndrome. Hum Mutat 2002, 20:236.
133. Williams CJ, Ganguly A, Considine E, et al. A-2-G transition at the 3' acceptor splice site of IVS17 characterizes the COL2A1 gene mutation in the original Stickler syndrome kindred. Am J Med Genet 1996, 63:461-467.
134. Vikkula M, Mariman EC, Lui VC, et al. Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus. Cell 1995, 80:431-437.
135. Snead MP, Yates JR, Pope FM, et al. Masked confirmation of linkage between type 1 congenital vitreous anomaly and COL 2A1 in Stickler syndrome [Letter]. Graefes Arch Clin Exp Ophthalmol 1996, 234:720-721.
136. Snead MP, Payne SJ, Barton DE, et al. Stickler syndrome: correlation between vitreoretinal phenotypes and linkage to COL 2A1. Eye 1994, 8:609-614.
137. Parentin F, Sangalli A, Mottes M, et al. Stickler syndrome and vitreoretinal degeneration: correlation between locus mutation and vitreous phenotype. Apropos of a case. Graefes Arch Clin Exp Ophthalmol 2001, 239:316-319.
138. Richards AJ, Baguley DM, Yates JR, et al. Variation in the vitreous phenotype of Stickler syndrome can be caused by different amino acid substitutions in the X position of the type II collagen Gly-X-Y triple helix. Am J Hum Genet 2000, 67:1083-1094.
139. Snead MP, Yates JR Clinical and molecular genetics of Stickler syndrome. J Med Genet 1999, 36:353-359.
140. Martin S, Richards AJ, Yates JR, et al. Stickler syndrome: further mutations in COL11A1 and evidence for additional locus heterogeneity. Eur J Hum Genet 1999, 7:807-814.
141. Richards AJ, Martin S, Yates JR, et al. COL2A1 exon 2 mutations: relevance to the Stickler and Wagner syndromes. Br J Ophthalmol 2000, 84:364-371.
142. Bishop PN, Reardon AJ, McLeod D, et al. Identification of alternatively spliced variants of type II procollagen in vitreous. Biochem Biophys Res Commun 1994, 203:289-295.
143. Reardon A, Sandell L, Jones CJ, et al. Localization of pN-type IIA procollagen on adult bovine vitreous collagen fibrils. Matrix Biol 2000, 19:169-173.
144. Sandell LJ, Morris N, Robbins JR, et al. Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: differential expression of the amino-propeptide. J Cell Biol 1991, 114:1307-1319.
145. Lui VC, Ng LJ, Nicholls J, et al. Tissue-specific and differential expression of alternatively spliced alpha 1(II) collagen mRNAs in early human embryos. Dev Dyn 1995, 203:198-211.
146. Sandberg MM, Hirvonen HE, Elima KJ, et al. Co-expression of collagens II and XI and alternative splicing of exon 2 of collagen II in several developing human tissues. Biochem J 1993, 294:595-602.
147. Nishiyama T, Hatano H, Kurosaka M, et al. Cis-acting intronic elements that regulate cartilage-specific alternative splicing of the type II collagen (Col2) pre-mRNA lie at or near splice site junction sequences flanking exon 2 of the gene. J Bone Miner Res 2003, 18:1716-1722.
148. Go SL, Maugeri A, Mulder JJ, et al. Autosomal dominant rhegmatogenous retinal detachment associated with an Arg453Ter mutation in the COL2A1 gene. Invest Ophthalmol Vis Sci 2003, 44:4035-4043.
149. Richards AJ, Morgan J, Bearcroft PW, et al. Vitreoretinopathy with phalangeal epiphyseal dysplasia, a type II collagenopathy resulting from a novel mutation in the C-propeptide region of the molecule. J Med Genet 2002, 39:661-665.
150. Engel J, Prockop DJ The zipper-like folding of collagen triple helices and the effects of mutations that disrupt the zipper. Ann Rev Biophys Chem 1991, 20:137-152.
151. Mortier GR, Weis M, Nuytinck L, et al. Report of five novel and one recurrent COL2A1 mutations with analysis of genotype-phenotype correlation in patients with a lethal type II collagen disorder. J Med Genet 2000, 37:263-271.
152. Unger S, Korkko J, Krakow D, et al. Double heterozygosity for pseudoachondroplasia and spondyloepiphyseal dysplasia congenita. Am J Med Genet 2001, 104:140-146.
153. Ballo R, Beighton PH, Ramesar RS Stickler-like syndrome due to a dominant negative mutation in the COL2A1 gene. Am J Med Genet 1998, 80:6-11.
154. Zabel B, Hilbert K, Stoss H, et al. A specific collagen type II gene (COL2A1) mutation presenting as spondyloperipheral dysplasia. Am J Med Genet 1996, 63:123-128.
155. Shanske AL, Bogdanow A, Shprintzen RJ, et al. The Marshall syndrome: report of a new family and review of the literature. Am J Med Genet 1997, 70:52-57.
156. Marshall D Ectodermal dysplasia; report of kindred with ocular abnormalities and hearing defect. Am J Ophthalmol 1958, 45:143-156.
157. Griffith AJ, Gebarski SS, Shepard NT, et al. Audiovestibular phenotype associated with a COL11A1 mutation in Marshall syndrome. Arch Otolaryngol Head Neck Surg 2000, 126:891-894.
158. Annunen S, Korkko J, Czarny M, et al. Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. Am J Hum Genet 1999, 65:974-983.
159. Griffith AJ, Sprunger LK, Sirko-Osadsa DA, et al. Marshall syndrome associated with a splicing defect at the COL11A1 locus. Am J Hum Genet 1998, 62:816-823.
160. Shanske A, Bogdanow A, Shprintzen RJ, et al. Marshall syndrome and a defect at the COL11A1 locus. Am J Hum Genet 1998, 63:1558-1561.
161. Kniest W Zur Abgrenzung der dysostosis enchondralis von der chondrodystrophie. Z Kinderheildk 1952, 70:633-640.
162. Spranger J, Winterpacht A, Zabel B Kniest dysplasia: Dr W. Kniest, his patient, the molecular defect. Am J Med Genet 1997, 69:79-84.
163. Spranger J, Menger H, Mundlos S, et al. Kniest dysplasia is caused by dominant collagen II (COL2A1) mutations: parental somatic mosaicism manifesting as Stickler phenotype and mild spondyloepiphyseal dysplasia. Pediatr Radiol 1994, 24:431-435.
164. Winterpacht A, Schwarze U, Mundlos S, et al. Alternative splicing as the result of a type II procollagen gene (COL2A1) mutation in a patient with Kniest dysplasia. Hum Mol Genet 1994, 3:1891-1893.
165. Winterpacht A, Superti-Furga A, Schwarze U, et al. The deletion of six amino acids at the C-terminus of the alpha 1 (II) chain causes overmodification of type II and type XI collagen: further evidence for the association between small deletions in COL2A1 and Kniest dysplasia. J Med Genet 1996, 33:649-654.
166. Winterpacht A, Hilbert M, Schwarze U, et al. Kniest and Stickler dysplasia phenotypes caused by collagen type II gene (COL2A1) defect. Nat Genet 1993, 3:323-326.
167. Farriaux JP, Remy J, Harris GB, et al. Severe neonatal dwarfism resembling the Kniest and Rolland types of chondrodysplasia. Acta Paediatr Belg 1977, 30:77-84.
168. Spranger JW, Maroteaux P Kniest disease. Birth Defects Orig Artic Ser 1974, 10:50-56.
169. Kagotani Y, Takao K, Nomura K, et al. [Two cases of Kniest dysplasia - ocular manifestations]. Nippon Ganka Gakkai Zasshi 1995, 99:376-383.
170. Yokoyama T, Nakatani S, Murakami A A case of Kniest dysplasia with retinal detachment and the mutation analysis. Am J Ophthalmol 2003, 136:1186-1188.
171. Wilkin DJ, Artz AS, South S, et al. Small deletions in the type II collagen triple helix produce kniest dysplasia. Am J Med Genet 1999, 85:105-112.
172. Fernandes RJ, Wilkin DJ, Weis MA, et al. Incorporation of structurally defective type II collagen into cartilage matrix in kniest chondrodysplasia. Arch Biochem Biophys 1998, 355:282-290.
173. Yang W, Cole WG Low basal transcripts of the COL2A1 collagen gene from lymphoblasts show alternative splicing of exon 12 in the Kniest form of spondyloepiphyseal dysplasia. Hum Mutat 1998, (Suppl 1):S1-S2.
174. Knobloch WH, Layer JM Retinal detachment and encephalocele. J Pediat Ophthal 1971, 8:181-184.
175. Czeizel AE, Goblyos P, Kustos G, et al. The second report of Knobloch syndrome. Am J Med Genet 1992, 42:777-779.
176. Seaver LH, Joffe L, Spark RP, et al. Congenital scalp defects and vitreoretinal degeneration: redefining the Knobloch syndrome. Am J Med Genet 1993, 46:203-208.
177. Passos-Bueno MR, Marie SK, Monteiro M, et al. Knobloch syndrome in a large Brazilian consanguineous family: confirmation of autosomal recessive inheritance. Am J Med Genet 1994, 52:170-173.
178. Wilson C, Aftimos S, Pereira A, et al. Report of two sibs with Knobloch syndrome (encephalocoele and viteroretinal degeneration) and other anomalies. Am J Med Genet 1998, 78:286-290.
179. Sniderman LC, Koenekoop RK, O'Gorman AM, et al. Knobloch syndrome involving midline scalp defect of the frontal region. Am J Med Genet 2000, 90:146-149.
180. Kliemann SE, Waetge RT, Suzuki OT, et al. Evidence of neuronal migration disorders in Knobloch syndrome: clinical and molecular analysis of two novel families. Am J Med Genet 2003, 119A:15-19.
181. Sertie AL, Quimby M, Moreira ES, et al. A gene which causes severe ocular alterations and occipital encephalocele (Knobloch syndrome) is mapped to 21q22.3. Hum Mol Genet 1996, 5:843-847.
182. Sertie AL, Sossi V, Camargo AA, et al. Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome). Hum Mol Genet 2000, 9:2051-2058.
183. Menzel O, Bekkeheien RC, Reymond A, et al. Knobloch syndrome: novel mutations in COL18A1, evidence for genetic heterogeneity, and a functionally impaired polymorphism in endostatin. Hum Mutat 2004, 23:77-84.
184. Suzuki OT, Sertie AL, Der Kaloustian VM, et al. Molecular analysis of collagen XVIII reveals novel mutations, presence of a third isoform, and possible genetic heterogeneity in Knobloch syndrome. Am J Hum Genet 2002, 71:1320-1329.
185. Fukai N, Eklund L, Marneros AG, et al. Lack of collagen XVIII/endostatin results in eye abnormalities. Embo J 2002, 21:1535-1544.
186. Weissenbacher G, Zweymueller E Gleichzeitiges vorkommen eines syndroms von pierre robin und einer fetalen chondrodysplasie. Monatsschr Kinderheilkd 1964, 112:315-317.
187. Chemke J, Carmi R, Galil A, et al. Weissenbacher-Zweymuller syndrome: a distinct autosomal recessive skeletal dysplasia. Am J Med Genet 1992, 43:989-995.
188. Pihlajamaa T, Prockop DJ, Faber J, et al. Heterozygous glycine substitution in the COL11A2 gene in the original patient with the Weissenbacher-Zweymuller syndrome demonstrates its identity with heterozygous OSMED (nonocular Stickler syndrome) [In process citation]. Am J Med Genet 1998, 80:115-120.
189. Insley J, Astley R A bone dysplasia with deafness. Br J Radiol 1974, 47:244-251.
190. Blair NP, Albert DM, Liberfarb RM, et al. Hereditary progressive arthro-ophthalmopathy of Stickler. Am J Ophthalmol 1979, 88:876-888.
191. Opitz JM, France T, Herrmann J, et al. The Stickler syndrome. N Engl J Med 1972, 286:546-547.
192. Wilkin DJ, Mortier GR, Johnson CL, et al. Correlation of linkage data with phenotype in eight families with Stickler syndrome. Am J Med Genet 1998, 80:121-127.
193. Stickler GB, Hughes W, Houchin P Clinical features of hereditary progressive arthro-ophthalmopathy (Stickler syndrome): a survey. Genet Med 2001, 3:192-196.
194. Richards AJ, Scott JD, Snead MP Molecular genetics of rhegmatogenous retinal detachment. Eye 2002, 16:388-392.
195. Liberfarb RM, Levy HP, Rose PS, et al. The Stickler syndrome: genotype/phenotype correlation in 10 families with Stickler syndrome resulting from seven mutations in the type II collagen gene locus COL2A1. Genet Med 2003, 5:21-27.
196. Temple IK Stickler's syndrome. J Med Genet 1989, 26:119-126.
197. Sheffield LJ, Reiss JA, Strohm K, et al. A genetic follow-up study of 64 patients with the Pierre Robin complex. Am J Med Genet 1987, 28:25-36.
198. Printzlau A, Andersen M Pierre Robin sequence in Denmark: a retrospective population-based epidemiological study. Cleft Palate Craniofac J 2004, 41:47-52.
199. Herrmann J, France TD, Opitz JM The Stickler syndrome. Birth Defects Orig Artic Ser 1975, 11:203-204.
200. Merrill KD, Schmidt TL Occipitoatlantal instability in a child with Kniest syndrome. J Pediatr Orthop 1989, 9:338-340.
201. Hirose T, Lee KY, Schepens CL Wagner's hereditary vitreoretinal degeneration and retinal detachment. Arch Ophthalmol 1973, 89:176-185.
202. Haider NB, Jacobson SG, Cideciyan AV, et al. Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate. Nat Genet 2000, 24:127-131.
203. Mitton KP, Swain PK, Khanna H, et al. Interaction of retinal bZIP transcription factor NRL with Flt3-interacting zinc-finger protein Fiz1: possible role of Fiz1 as a transcriptional repressor. Hum Mol Genet 2003, 12:365-373.
204. Yanagi Y, Takezawa S, Kato S Distinct functions of photoreceptor cell-specific nuclear receptor, thyroid hormone receptor beta2 and CRX in one photoreceptor development. Invest Ophthalmol Vis Sci 2002, 43:3489-3494.
205. Marmor MF, Jacobson SG, Foerster MH, et al. Diagnostic clinical findings of a new syndrome with night blindness, maculopathy, and enhanced S cone sensitivity. Am J Ophthalmol 1990, 110:124-134.
206. Jacobson SG, Roman AJ, Roman MI, et al. Relatively enhanced S cone function in the Goldmann-Favre syndrome. Am J Ophthalmol 1991, 111:446-453.
207. Sharon D, Sandberg MA, Caruso RC, et al. Shared mutations in NR2E3 in enhanced S-cone syndrome, Goldmann-Favre syndrome, and many cases of clumped pigmentary retinal degeneration. Arch Ophthalmol 2003, 121:1316-1323.
208. Favre M [Two cases of hyaloid-retinal degeneration.]. Ophthalmologica 1958, 135:604-609.
209. Francois J, Rouck Ad, Cambie E [Goldmann-Favre vitreo-tapeto-retinal degeneration]. Ophthalmologica 1974, 168:81-96.
210. Goldmann H La biomicroscopie du corps vitre et du fond de l'oeil. Bull Med Soc Fr Ophthalmol 1957, 70:265-272.
211. Fishman GA, Jampol LM, Goldberg MF Diagnostic features of the Favre-Goldmann syndrome. Br J Ophthalmol 1976, 60:345-353.
212. Hood DC, Cideciyan AV, Roman AJ, et al. Enhanced S cone syndrome: evidence for an abnormally large number of S cones. Vision Res 1995, 35:1473-1481.
213. Marmor MF, Tan F, Sutter EE, et al. Topography of cone electrophysiology in the enhanced S cone syndrome. Invest Ophthalmol Vis Sci 1999, 40:1866-1873.
214. Milam AH, Rose L, Cideciyan AV, et al. The nuclear receptor NR2E3 plays a role in human retinal photoreceptor differentiation and degeneration. Proc Natl Acad Sci USA 2002, 99:473-478.
215. Peyman GA, Fishman GA, Sanders DR, et al. Histopathology of Goldmann-Favre syndrome obtained by full-thickness eye-wall biopsy. Ann Ophthalmol 1977, 9:479-484.
216. Haider NB, Naggert JK, Nishina PM Excess cone cell proliferation due to lack of a functional NR2E3 causes retinal dysplasia and degeneration in rd7/rd7 mice. Hum Mol Genet 2001, 10:1619-1626.
217. Deutman AF Vitreoretinal dystrophies. Krill's hereditary retinal and choroidal diseases 1977, Harper and Row, Philadelphia. A.E. Krill (Ed.).
218. Feiler-Ofry V, Adam A, Regenbogen L, et al. Hereditary vitreoretinal degeneration and night blindness. Am J Ophthalmol 1969, 67:553-558.
219. Carr RE, Siegel IM The vitreo-tapeto-retinal degenerations. Arch Ophthalmol 1970, 84:436-441. passim.
220. Khairallah M, Ladjimi A, Ben Yahia S, et al. Elevated macular retinoschisis associated with Goldmann-Favre syndrome successfully treated with grid laser photocoagulation. Retina 2002, 22:234-237.
221. Kaufman SJ, Goldberg MF, Orth DH, et al. Autosomal dominant vitreoretinochoroidopathy. Arch Ophthalmol 1982, 100:272-278.
222. Blair NP, Goldberg MF, Fishman GA, et al. Autosomal dominant vitreoretinochoroidopathy (ADVIRC). Br J Ophthalmol 1984, 68:2-9.
223. Han DP, Lewandowski MF Electro-oculography in autosomal dominant vitreoretinochoroidopathy. Arch Ophthalmol 1992, 110:1563-1567.
224. Traboulsi EI, Payne JW Autosomal dominant vitreoretinochoroidopathy. Report of the third family. Arch Ophthalmol 1993, 111:194-196.
225. Francois P, Puech B, Hache JC, et al. [Vitreoretinochoroidal heredo-dystrophy, microcornea, glaucoma and cataract]. J Fr Ophtalmol 1993, 16:29-40.
226. Roider J, Fritsch E, Hoerauf H, et al. Autosomal dominant vitreoretinochoroidopathy. Retina 1997, 17:294-299.
227. Kellner U, Jandeck C, Kraus H, et al. Autosomal dominant vitreoretinochoroidopathy with normal electrooculogram in a German family. Graefes Arch Clin Exp Ophthalmol 1998, 236:109-114.
228. Lafaut BA, Loeys B, Leroy BP, et al. Clinical and electrophysiological findings in autosomal dominant vitreoretinochoroidopathy: report of a new pedigree. Graefes Arch Clin Exp Ophthalmol 2001, 239:575-582.
229. Sarra GM, Weigell-Weber M, Kotzot D, et al. Clinical description and exclusion of candidate genes in a novel autosomal recessively inherited vitreoretinal dystrophy. Arch Ophthalmol 2003, 121:1109-1116.
230. Weigell-Weber M, Sarra GM, Kotzot D, et al. Genomewide homozygosity mapping and molecular analysis of a candidate gene located on 22q13 (fibulin-1) in a previously undescribed vitreoretinal dystrophy. Arch Ophthalmol 2003, 121:1184-1188.
231. Daniel R, Kanski JJ, Glasspool MG Hyalo-retinopathy in the clefting syndrome. Br J Ophthalmol 1974, 58:96-102.
232. Godel V, Regenbogen L, Feiler-Ofry V, et al. Vitreoretinal degeneration in facial clefting syndrome. Birth Defects Orig Artic Ser 1982, 18:581-586.
233. Fryns JP MCA/MR syndrome with severe pre- and postnatal growth retardation, deep mental retardation, distinct facial appearance with nasal hypoplasia, cleft palate and retino-choroidal coloboma in two unrelated female patients. Genet Couns 2000, 11:399-402.
234. Richieri-Costa A, Guion-Almeida ML Short stature, mental retardation, eye anomalies, and cleft lip/palate. Am J Med Genet 1992, 42:449-452.
235. Nothen MM, Knopfle G, Fodisch HJ, et al. Steinfeld syndrome: report of a second family and further delineation of a rare autosomal dominant disorder. Am J Med Genet 1993, 46:467-470.
236. Ayme S, Julian C, Gambarelli D, et al. Fryns syndrome: report on 8 new cases. Clin Genet 1989, 35:191-201.
237. Jensen OA, Hagerstrand I, Brun A, et al. Limb-body wall complex with anophthalmos and choroidal coloboma. Pediatr Pathol 1993, 13:505-517.
238. Majewski F, Kim MA, Haberlandt WF, et al. [Reciprocal translocation t (5p-; 19p+) in three generations (author's transl)]. Z Kinderheilkd 1975, 120:223-230.
239. van Kempen AA, Nabben FA, Hamel BC Heminasal aplasia: a case report and review of the literature of the last 25 years. Clin Dysmorphol 1997, 6:147-152.
240. Wald KJ, Hirose T Ectodermal dysplasia, ectrodactyly, and clefting syndrome and bilateral retinal detachment. Arch Ophthalmol 1993, 111:734.
241. Jampol LM, Ebroon DA, Goldbaum MH Peripheral proliferative retinopathies: an update on angiogenesis, etiologies and management. Surv Ophthalmol 1994, 38:519-540.
242. Bennett SR, Folk JC, Kimura AE, et al. Autosomal dominant neovascular inflammatory vitreoretinopathy. Ophthalmology 1990, 97:1125-1135. discussion 1135-1136.
243. Stone EM, Kimura AE, Folk JC, et al. Genetic linkage of autosomal dominant neovascular inflammatory vitreoretinopathy to chromosome 11q13. Hum Mol Genet 1992, 1:685-689.
244. Gitter KA, Rothschild H, Waltman DD, et al. Dominantly inherited peripheral retinal neovascularization. Arch Ophthalmol 1978, 96:1601-1605.
245. Criswick VG, Schepens CL Familial exudative vitreoretinopathy. Am J Ophthalmol 1969, 68:578-594.
246. Pendergast SD, Trese MT Familial exudative vitreoretinopathy. Results of surgical management. Ophthalmology 1998, 105:1015-1023.
247. Javellana JA, Drouilhet JH, Kokame GT, et al. Retinal capillary angioma in familial exudative vitreoretinopathy treated with photodynamic therapy. Am J Ophthalmol 2004, 137:780-782.
248. Shukla D, Singh J, Sudheer G, et al. Familial exudative vitreoretinopathy (FEVR). Clinical profile and management. Indian J Ophthalmol 2003, 51:323-328.
249. Toomes C, Downey LM, Bottomley HM, et al. Identification of a fourth locus (EVR4) for familial exudative vitreoretinopathy (FEVR). Mol Vis 2004, 10:37-42.
250. Downey LM, Keen TJ, Roberts E, et al. A new locus for autosomal dominant familial exudative vitreoretinopathy maps to chromosome 11p12-13. Am J Hum Genet 2001, 68:778-781.
251. Alsheikheh A, Lieb W, Grehn F. [Criswick-Schepens syndrome - familial exudative vitreoretinopathy. Report of six cases in two consanguineous families]. Ophthalmologe 2004.
252. de Crecchio G, Simonelli F, Nunziata G, et al. Autosomal recessive familial exudative vitreoretinopathy: evidence for genetic heterogeneity. Clin Genet 1998, 54:315-320.
253. Robitaille J, MacDonald ML, Kaykas A, et al. Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat Genet 2002, 32:326-330.
254. Toomes C, Bottomley HM, Jackson RM, et al. Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. Am J Hum Genet 2004, 74:721-730.
255. Xu Q, Wang Y, Dabdoub A, et al. Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 2004, 116:883-895.